Cellgate, Progen deal

Progen acquired CellGate for about US$1.5 million in stock and up to

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE